Half of Moderna’s Coronavirus Vaccine Owned by NIH?

• Half of Moderna’s Coronavirus Vaccine Owned by NIH?
  by Ethan Huff, https://www.intellihub.com/
  Axios and Public Citizen have obtained new documents suggesting that the National Institutes of Health (NIH) owns half of the key patent on Moderna’s up-and-coming vaccine for the Wuhan coronavirus (COVID-19).
  –
  Should the vaccine come to market, the NIH will reportedly collect half of the royalties associated with its distribution. At the same time, four NIH scientists have filed provisional patents on their own claiming to be “co-inventors” of the experimental jab.
  –
  Many people do not know this, but the current cap on royalties for agency scientists who help develop a vaccine is set at $150,000. This means that there is a financial incentive to attach one’s name to vaccine development, incentivizing the creation of potentially useless and dangerous new drugs.
  –
  This discovery by Axios and Public Citizen probably explains why National Institutes of Allergy and Infectious Diseases (NIAID) head Anthony Fauci moved Modern’s vaccine for the Wuhan coronavirus (COVID-19) to the front of the line, despite there being many other candidates vying for a piece of pie.
  –
  Amazingly, Fauci allowed Moderna to skip animal trials entirely and move straight to human trials. This was a potentially life-threatening decision that will now put thousands or even millions of human lives at risk.
  –
  “Every prior coronavirus vaccine has proven problematic and can be lethal to animals due to COVID’s unique penchant for ‘pathogenic priming,’” reports Children’s Health Defense (CHD). “Death occurs only after a vaccinated animal encounters the wild virus.”
  –
  First one billion doses of Moderna’s experimental coronavirus vaccine in the works, despite the jab killing people
  Many scientists and public health advocates have criticized Fauci over this decision, which they have dubbed as reckless. But this did not stop him from awarding the company a whopping $483 million grant through the Biomedical Advanced Research and Development Authority (BARDA), which is said to be a sister agency to the NIH.
  –
  read more.

end